TherapeuticsMD, Inc. (NYSE MKT: TXMD), a women’s healthcare company ("TherapeuticsMD" or the "Company"), will host a conference call and live audio webcast to disclose its financial results for the quarter ended March 31, 2014. The call and webcast will be held on Monday, May 5, 2014 at 4:30pm EDT and will be hosted by Robert Finizio, Co-Founder and Chief Executive Officer, and Dan Cartwright, Chief Financial Officer. Call and webcast specifics follow:
|Date||Monday, May 5, 2014|
|Telephone access: U.S. and Canada||800-753-0594|
|Telephone access: International||212-231-2911|
|Access code for all callers||21714227|
|Live audio webcast||
www.therapeuticsmd.comSee Events and Presentations on Investors tab
Shortly after completion of the call and webcast, an audio replay will be made available for on-demand listening until 11:59 pm EDT on May 26, 2014. The audio replay will be posted on the Company's website at www.therapeuticsmd.com under Events and Presentations on the Investors tab and will also be available by dialing 800-633-8284 in the U.S. and Canada, or 402-977-9140 for international callers. The access code for all callers is 21714227.
About TherapeuticsMD, Inc.
TherapeuticsMD, Inc. is a women’s healthcare company focused on developing and commercializing products targeted exclusively for women. We are developing advanced hormone therapy pharmaceutical products based on novel technologies that enable delivery of bioidentical hormones through a variety of dosage forms and administration routes. We also manufacture and distribute branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins and cosmetics, under our vitaMedMD
® and BocaGreenMD
® brands. More information is available at the following websites: